SPECTRAWAVE, INC. – Trademark Portfolio
Entity Type: 03
SPECTRAWAVE, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 3 are pending. Notable registered marks include STARLIGHT and SPECTRAWAVE. The owner is based in WALTHAM, MA.
179 Bear Hill Road
WALTHAM, MA 02451
Showing of trademarks Trademarks
Trademark Classifications
SPECTRAWAVE, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SPECTRAWAVE, INC. have?
SPECTRAWAVE, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending, 1 abandoned.
What trademark classes does SPECTRAWAVE, INC. file in?
SPECTRAWAVE, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SPECTRAWAVE, INC.'s most well-known trademarks?
SPECTRAWAVE, INC.'s registered trademark portfolio includes well-known marks such as STARLIGHT and SPECTRAWAVE. These are among 2 currently registered trademarks in the portfolio.
What is SPECTRAWAVE, INC.'s trademark registration success rate?
SPECTRAWAVE, INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 3 applications are pending review.